Towards personalized tumor markers

The cancer biomarker discovery pipeline is progressing slowly. The difficulties of finding novel and effective biomarkers for diagnosis and management of cancer patients are well-known. We speculate that it is unlikely to discover new serological biomarkers characterized by high sensitivity and spec...

Descripción completa

Detalles Bibliográficos
Autores principales: Kulasingam, Vathany, Prassas, Ioannis, Diamandis, Eleftherios P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2017
Materias:
Correspondence
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5871887/
https://www.ncbi.nlm.nih.gov/pubmed/29872704
http://dx.doi.org/10.1038/s41698-017-0021-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5871887/
https://www.ncbi.nlm.nih.gov/pubmed/29872704
http://dx.doi.org/10.1038/s41698-017-0021-2

Ejemplares similares